Page results
-
If your doctor has referred you for a blood test, please book your phlebotomy (blood test) appointment online in advance.
-
UCLH is committed to following a set of principles on how the trust will use routinely collected patient data for research. The principles will enable vital health research to take place, while at the same time protecting and using clinical data as patients would expect.
-
This page answers common questions about Acute Pancreatitis and how it is managed in North Central London (NCL).
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
-
This page provides information on Ulcerative Colitis (UC) and how diet can help you manage any symptoms you are managing, improve wellbeing and support a healthy diet during remission.
-
This page provides information on how diet can help to manage the symptoms of Ulcerative Colitis during a flare up known as active Ulcerative Colitis.
-
HTD Outpatients offers a wide range of clinics for Chagas disease, Infectious diseases, Leishmaniasis, Leprosy , Malaria , Microbiology, Neglected tropical diseases, Parasitology
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
Easy read information for patients living with a catheter.
File results
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments